Abstract:Hexavalent chromium (Cr(VI)) has been identified as a Class I human carcinogen, but its carcinogenic mechanism is currently unclear. There is still a lack of understanding of its associations with early pulmonary inflammatory damages. Inflammation is an important stage before the occurrence of tumors, and under the long-term stimulation of inflammation, it can promote the development of tumors. In this study, the aim is to explore the effect of Cr(VI) exposure on pulmonary inflammation and its relationship with the mechanism of inflammation cancer transformation. We established a Cr(VI) exposure model in SD rats using tracheal instillation of potassium dichromate solution, and collected samples at the time of cessation of exposure and 14 days after cessation of exposure. Analyzing the experimental results, it was found that the lung index increased after exposure to Cr(VI), promoting the occurrence of apoptosis in lung tissue cells and exacerbating lung tissue damage. The damage situation improved after exposure termination; Inductively coupled plasma mass (ICPRQ) spectrometer detection found that the exposed group had significantly increased levels of blood chromium, blood manganese, blood copper, blood arsenic, urine chromium, urine copper, and urine lead; After two weeks of repair, blood chromium and blood manganese levels were significantly lower than those in the same dose group of the exposure group, while blood copper levels were significantly higher than those in the same dose group of the exposure group. There was no significant difference in blood arsenic levels between the exposure group and the exposure group. Urine chromium and urine lead levels were significantly lower than those in the same dose group of the exposure group, while urine copper levels only increased. At the same time, it was found that Cr(VI) exposure caused disruption of oxidative stress levels in rat lung tissues. After 14-day exposure, Cr(VI) significantly decreased and oxidative stress levels significantly decreased. Further investigation revealed that Cr(VI) induces activation of inflammasomes NLRP3, AIM2, and their signaling pathways in lung inflammatory injuries, but this condition persists even after cessation of exposure. The study suggested that in hexavalent chromium induced lung tissue injuries in rats, NLRP3 and AIM2 inflammasomes and their signaling pathways activation. Furthermore, the characteristic of sustained activation after cessation of exposure was also indicated. These results provide new ideas and references for further elucidating the mechanisms of Cr(VI), lung inflammation and inflammation cancer transformation.

Cr(VI) increases tyrosine phosphorylation through reactive oxygen species-mediated reactions

Reactive Oxygen Species Mediate Cr(VI)-induced Carcinogenesis Through PI3K/AKT-dependent Activation of GSK-3β/β-catenin Signaling.

On the mechanism of Cr (VI)‐induced carcinogenesis: Dose dependence of uptake and cellular responses

Constitutive Activation of Epidermal Growth Factor Receptor Promotes Tumorigenesis of Cr(VI)-transformed Cells through Decreased Reactive Oxygen Species and Apoptosis Resistance Development

The Role of Hydroxyl Radical As a Messenger in Cr(VI)-induced P53 Activation.

Cr(VI) induces cytotoxicity in vitro through activation of ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction via the PI3K/Akt signaling pathway

P-352 HEXAVALENT CHROMIUM CAUSED DNA DAMAGE RESPONSE AND APOPTOSIS VIA THE PI3K/AKT/FOXO1 PATHWAY TRIGGERED BY OXIDATIVE STRESS IN LUNG OF RAT

Cr(Vi) Induces Mitochondrial-Mediated and Caspase-Dependent Apoptosis Through Reactive Oxygen Species-Mediated P53 Activation in Jb6 Cl41 Cells

Reactive Oxygen Species Mediate Cr(Vi)-Induced S Phase Arrest Through P53 in Human Colon Cancer Cells

Chromium(VI)-induced nuclear factor-kappa B activation in intact cells via free radical reactions.

Cr(IV) Causes Activation of Nuclear Transcription Factor-Κb, DNA Strand Breaks and Dg Hydroxylation Via Free Radical Reactions

Cr (VI) Induces Crosstalk Between Apoptosis and Autophagy Through Endoplasmic Reticulum Stress in A549 Cells.

Cr (VI) induces abnormalities in glucose and lipid metabolism through ROS/Nrf2 signaling

Molecular Mechanisms Of Chromium-Induced Carcinogenesis

Role of Reactive Oxygen Species and P53 in Chromium(VI)-induced Apoptosis

Role of Reactive Oxygen Species and Cr(VI) in Ras-mediated Signal Transduction.

Involvement of Calcium, Reactive Oxygen Species, and ATP in Hexavalent Chromium-Induced Damage in Red Blood Cells.

Hexavalent Chromium Cr(VI) Up-Regulates COX-2 Expression Through an NFκB/c-Jun/AP-1–Dependent Pathway

Oxidative Stress and Chromium(VI) Carcinogenesis

Effects of hexavalent chromium on mitochondria and their implications in carcinogenesis

Hexavalent chromium exposure induces lung injury via activation of NLRP3 and AIM2 inflammasomes in rats